NYSE:SYK - Stryker Stock Price, Forecast & News

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

Stryker announced a quarterly dividend on Thursday, December 5th. Investors of record on Tuesday, December 31st will be paid a dividend of $0.575 per share on Friday, January 31st. This represents a $2.30 dividend on an annualized basis and a yield of 1.07%. The ex-dividend date is Monday, December 30th. This is a positive change from Stryker's previous quarterly dividend of $0.52. View Stryker's Dividend History.

Stryker Co. (NYSE:SYK) posted its quarterly earnings results on Tuesday, January, 28th. The medical technology company reported $2.49 EPS for the quarter, topping analysts' consensus estimates of $2.46 by $0.03. The medical technology company earned $4.13 billion during the quarter, compared to the consensus estimate of $4.11 billion. Stryker had a return on equity of 25.33% and a net margin of 23.55%. Stryker's quarterly revenue was up 8.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.18 EPS. View Stryker's Earnings History.

Stryker is scheduled to release their next quarterly earnings announcement on Tuesday, January 28th 2020. View Earnings Estimates for Stryker.

Stryker issued an update on its FY20 earnings guidance on Tuesday, January, 28th. The company provided EPS guidance of $9.00-9.20 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $9.04.

20 brokerages have issued 12 month target prices for Stryker's shares. Their forecasts range from $179.00 to $245.00. On average, they anticipate Stryker's stock price to reach $222.56 in the next twelve months. This suggests a possible upside of 3.9% from the stock's current price. View Analyst Price Targets for Stryker.

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 6 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Stryker.

News articles about SYK stock have been trending positive on Tuesday, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Stryker earned a news impact score of 3.0 on InfoTrie's scale. They also assigned news headlines about the medical technology company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Stryker.

Stryker saw a increase in short interest in the month of January. As of January 15th, there was short interest totalling 3,910,000 shares, an increase of 10.8% from the December 31st total of 3,530,000 shares. Based on an average trading volume of 1,370,000 shares, the days-to-cover ratio is currently 2.9 days. Approximately 1.1% of the shares of the company are short sold. View Stryker's Current Options Chain.

Some companies that are related to Stryker include Abbott Laboratories (ABT), Medtronic (MDT), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Hologic (HOLX), Varian Medical Systems (VAR), Steris (STE) and Insulet (PODD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Johnson & Johnson (JNJ), Visa (V), Walt Disney (DIS), Home Depot (HD), AbbVie (ABBV), Abbott Laboratories (ABT), Boeing (BA), NVIDIA (NVDA), CVS Health (CVS) and Medtronic (MDT).

Stryker's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include California Public Employees Retirement System (0.37%), Loring Wolcott & Coolidge Fiduciary Advisors LLP MA (0.34%), Fenimore Asset Management Inc. (0.14%), Welch & Forbes LLC (0.14%), Strs Ohio (0.14%) and State of Michigan Retirement System (0.12%). Company insiders that own Stryker stock include Allan C Golston, Bijoy Sagar, David Floyd, Glenn S Boehnlein, Graham A Mclean, Howard E Cox Jr, Katherine Ann Owen, Kevin Lobo, Lonny J Carpenter, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Roch Doliveux, Srikant M Datar, Timothy J Scannell, William E Berry Jr and Yin C Becker. View Institutional Ownership Trends for Stryker.

SYK stock was sold by a variety of institutional investors in the last quarter, including Retirement Systems of Alabama, Martin Investment Management LLC, SG Americas Securities LLC, Moody Lynn & Lieberson LLC, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Dupont Capital Management Corp, MU Investments Co. Ltd. and Zurcher Kantonalbank Zurich Cantonalbank. Company insiders that have sold Stryker company stock in the last year include Allan C Golston, Bijoy Sagar, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Srikant M Datar, Timothy J Scannell and Yin C Becker. View Insider Buying and Selling for Stryker.

SYK stock was acquired by a variety of institutional investors in the last quarter, including PGGM Investments, Commerzbank Aktiengesellschaft FI, Empire Life Investments Inc., Johanson Financial Advisors Inc., LVM Capital Management Ltd. MI, California Public Employees Retirement System, Mckinley Capital Management LLC Delaware and New York State Teachers Retirement System. View Insider Buying and Selling for Stryker.

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of SYK stock can currently be purchased for approximately $214.20.

Stryker has a market capitalization of $80.13 billion and generates $13.60 billion in revenue each year. The medical technology company earns $3.55 billion in net income (profit) each year or $7.31 on an earnings per share basis. Stryker employs 36,000 workers across the globe.View Additional Information About Stryker.

The official website for Stryker is http://www.strykercorp.com/.

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at 269-389-2600 or via email at [email protected]